Longest Known Survivor With HeartMate II Continuous‐Flow Left Ventricular Assist System—A Case Report of the 16‐Year Success Story
ABSTRACT Left ventricular assist devices (LVADs) have been used as a bridge to transplantation in patients with advanced heart failure. In this case, LVAD therapy was used as a destination therapy for 16 years, representing the longest documented and continuously ongoing support with the original im...
Saved in:
Main Authors: | Yamane Chawa, Mhd Baraa Habib, Ammar Chapra, Salah Elbdri |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.9695 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparing short‐term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®
by: Rene Schramm, et al.
Published: (2020-06-01) -
HeartMate 3 upgrade and aortic root replacement for severe aortic insufficiency and ventricular fibrillation
by: Katlin T. Schmitz, MD, et al.
Published: (2025-05-01) -
Pregnancy with a Left Ventricular Assist Device: A Narrative Review
by: Matthew S. Abraham, et al.
Published: (2025-01-01) -
Outcomes of Left Ventricular Assist Devices as Destination Therapy: A Systematic Review with Meta-Analysis
by: Emad Ali Al Khoufi
Published: (2025-01-01) -
Myocardial functional recovery following durable ventricular assist device in children
by: Bhavikkumar Langanecha, et al.
Published: (2025-02-01)